Zero Point Five Therapeutics
PrivateLast Round
Series C
Apr 17, 2025
Total Funding Raised
$20.2M
Company Overview
Zero Point Five Therapeutics is a biotechnology company that develops therapeutics aimed at treating soil-transmitted helminthiasis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zero Point Five Therapeutics Comparables
Compare Zero Point Five Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oxfendazole Development Group | 76% | |
| Johnson & Johnson | 72% | |
| Medicines Development for Global Health | 68% |
Zero Point Five Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 17, 2025 | ||||
| Series B | Jul 19, 2023 | ||||
| Seed | Sep 2, 2022 | ||||
| Series A | Feb 5, 2021 |
Zero Point Five Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Next Act Fund | Series A |
| Portfolia | Seed, Series B, Series A |
| TEDCO | Series C, Seed, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 19, 2023
$7.2M round led by Portfolia.
Zero Point Five Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Zero Point Five Therapeutics's valuation, stock price, and market status.
Is Zero Point Five Therapeutics a public or private company?
Zero Point Five Therapeutics is a private company.
What is the current stock price of Zero Point Five Therapeutics?
Zero Point Five Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Zero Point Five Therapeutics worth (valuation)?
Valuation information for Zero Point Five Therapeutics is not publicly available.
Can I buy Zero Point Five Therapeutics stock?
Zero Point Five Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Zero Point Five Therapeutics's last funding round?
Zero Point Five Therapeutics's most recent funding round was Series A on July 17, 2023.
Who are the main investors in Zero Point Five Therapeutics?
Key investors in Zero Point Five Therapeutics include Portfolia.
Will Zero Point Five Therapeutics IPO soon?
No public IPO plans have been announced for Zero Point Five Therapeutics.
How can I track Zero Point Five Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zero Point Five Therapeutics's secondary market activity and sign up for updates.